Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

Tabák AG, Carstensen M, Witte DR, Brunner EJ, Shipley MJ, Jokela M, Roden M, Kivimäki M, Herder C.

Diabetes Care. 2012 Dec;35(12):2540-7. doi: 10.2337/dc11-2263. Epub 2012 Aug 28.

2.

Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study.

Carstensen M, Herder C, Kivimäki M, Jokela M, Roden M, Shipley MJ, Witte DR, Brunner EJ, Tabák AG.

Diabetes. 2010 May;59(5):1222-7. doi: 10.2337/db09-1199. Epub 2010 Feb 25.

3.

Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and inflammation: Whitehall II study.

Tabák AG, Brunner EJ, Miller MA, Karanam S, McTernan PG, Cappuccio FP, Witte DR.

Horm Metab Res. 2009 Aug;41(8):626-9. doi: 10.1055/s-0029-1216359. Epub 2009 Apr 15.

4.

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G, Funahashi T, Matsuzawa Y, Shimomura I, Dekker JM.

Diabetes Care. 2006 Nov;29(11):2498-503.

PMID:
17065691
5.

Association of subclinical inflammation with deterioration of glycaemia before the diagnosis of type 2 diabetes: the KORA S4/F4 study.

Klüppelholz B, Thorand B, Koenig W, de Las Heras Gala T, Meisinger C, Huth C, Giani G, Franks PW, Roden M, Rathmann W, Peters A, Herder C.

Diabetologia. 2015 Oct;58(10):2269-77. doi: 10.1007/s00125-015-3679-4. Epub 2015 Jul 9.

PMID:
26155746
6.

Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.

Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M, Tominaga M, Kato T; Funagata study..

Diabetes Care. 2003 Jul;26(7):2015-20.

PMID:
12832305
7.

Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study.

Tabák AG, Kivimäki M, Brunner EJ, Lowe GD, Jokela M, Akbaraly TN, Singh-Manoux A, Ferrie JE, Witte DR.

Eur J Endocrinol. 2010 Jul;163(1):89-95. doi: 10.1530/EJE-10-0277.

8.

Sex differences in glucose and insulin trajectories prior to diabetes diagnosis: the Whitehall II study.

Vistisen D, Witte DR, Tabák AG, Brunner EJ, Kivimäki M, Færch K.

Acta Diabetol. 2014 Apr;51(2):315-9. doi: 10.1007/s00592-012-0429-7. Epub 2012 Sep 16.

PMID:
22983665
9.

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study.

Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabák AG, Schloot NC, Witte DR.

Diabetes Care. 2009 Mar;32(3):421-3. doi: 10.2337/dc08-1161. Epub 2008 Dec 10.

10.

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.

Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, Chen M.

Diabetes Res Clin Pract. 2006 Jun;72(3):244-50. Epub 2005 Dec 27.

PMID:
16377022
12.

Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: six-year follow-up.

Li Y, Yatsuya H, Iso H, Toyoshima H, Tamakoshi K.

Diabetes Metab Res Rev. 2012 May;28(4):349-56. doi: 10.1002/dmrr.2277.

PMID:
22228701
13.

Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.

Graessler J, Gruber M, Radke RB, Kopprasch S, Schwarz PE, Kamke W, Bornstein SR, Fischer S.

Gerontology. 2011;57(4):316-26. doi: 10.1159/000316575. Epub 2010 Jun 11.

PMID:
20551622
14.

Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study.

Ikehara S, Tabák AG, Akbaraly TN, Hulmán A, Kivimäki M, Forouhi NG, Iso H, Brunner EJ.

Diabetologia. 2015 Mar;58(3):534-42. doi: 10.1007/s00125-014-3448-9. Epub 2014 Nov 28.

15.

Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population.

Jalovaara K, Santaniemi M, Timonen M, Jokelainen J, Kesäniemi YA, Ukkola O, Keinänen-Kiukaanniemi S, Rajala U.

Metabolism. 2008 Aug;57(8):1130-4. doi: 10.1016/j.metabol.2008.03.019.

PMID:
18640392
16.

Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians.

Snehalatha C, Mukesh B, Simon M, Viswanathan V, Haffner SM, Ramachandran A.

Diabetes Care. 2003 Dec;26(12):3226-9.

PMID:
14633806
17.

Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.

Hulman A, Simmons RK, Brunner EJ, Witte DR, Færch K, Vistisen D, Ikehara S, Kivimaki M, Tabák AG.

Diabetologia. 2017 Apr 13. doi: 10.1007/s00125-017-4275-6. [Epub ahead of print]

PMID:
28409212
18.

Adiponectin and bariatric surgery: associations with diabetes and cardiovascular disease in the Swedish Obese Subjects Study.

Herder C, Peltonen M, Svensson PA, Carstensen M, Jacobson P, Roden M, Sjöström L, Carlsson L.

Diabetes Care. 2014 May;37(5):1401-9. doi: 10.2337/dc13-1362. Epub 2014 Feb 26.

PMID:
24574342
19.

Gender-dependent effects of metformin on vaspin and adiponectin in type 2 diabetes patients: a randomized clinical trial.

Esteghamati A, Mousavizadeh M, Noshad S, Zandieh A, Zarei H, Nakhjavani M.

Horm Metab Res. 2013 Apr;45(4):319-25. doi: 10.1055/s-0032-1330008. Epub 2012 Dec 7.

PMID:
23225237
20.

Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.

Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

Clin Endocrinol (Oxf). 2004 Jul;61(1):75-80.

PMID:
15212647

Supplemental Content

Support Center